Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interferon-inducer antivirals: Potential candidates to combat COVID-19
Ashkan Bagheri, Seyed Mohammad Iman Moezzi, Pouria Mosaddeghi, et al.
International Immunopharmacology (2020) Vol. 91, pp. 107245-107245
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
Supreeti Mahajan, Shweta Choudhary, Pravindra Kumar, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116356-116356
Open Access | Times Cited: 78
Administration of COVID-19 vaccines in immunocompromised patients
Manica Negahdaripour, Mojtaba Shafiekhani, Seyed Mohammad Iman Moezzi, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108021-108021
Open Access | Times Cited: 72
Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)
Monic Andrew, G. Jayaraman
Carbohydrate Research (2021) Vol. 505, pp. 108326-108326
Open Access | Times Cited: 67
Advances in Research on Antiviral Activities of Sulfated Polysaccharides from Seaweeds
Qiang Wei, Guoqiang Fu, Ke Wang, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 581-581
Open Access | Times Cited: 38
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines
Issa Sadeghian, Reza Heidari, Sara Sadeghian, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 169, pp. 106094-106094
Open Access | Times Cited: 37
The effect of vitamin D, magnesium and zinc supplements on interferon signaling pathways and their relationship to control SARS-CoV-2 infection
Mohsen Nabi‐Afjadi, Hadis Karami, Kaveh Goudarzi, et al.
Clinical and Molecular Allergy (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 27
Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
Hsiang‐Chi Huang, Shih‐Han Wang, Guo‐Chen Fang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 10
Type I interferon pathway genetic variants in severe COVID-19
Artur Fontenelle Lima Montenegro, Marco Clementino, Juliana Navarro Ueda Yaochite
Virus Research (2024) Vol. 342, pp. 199339-199339
Open Access | Times Cited: 3
Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients
Mahdie Rahban, Agata Stanek, Amirreza Hooshmand, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 4802-4802
Open Access | Times Cited: 20
Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line
Abdelrahman Y. Sherif, Gamaleldin I. Harisa, Fars K. Alanazi, et al.
AAPS PharmSciTech (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 14
Analytical approaches for determination of COVID-19 candidate drugs in human biological matrices
Rabee Mahdavi, Zahra Talebpour
TrAC Trends in Analytical Chemistry (2023) Vol. 160, pp. 116964-116964
Open Access | Times Cited: 8
Interferon signaling and ferroptosis in tumor immunology and therapy
Wei Hu, Ziqian Zhao, Jianxin Du, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
A Multidisciplinary Approach to Coronavirus Disease (COVID-19)
Aliye Gediz Ertürk, Arzu Şahin, Ebru Batı Ay, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3526-3526
Open Access | Times Cited: 19
Is N-acetylcysteine effective in treating patients with coronavirus disease 2019? A meta-analysis
Chih‐Hao Chen, K.C. Hung, Chii-Yuan Huang, et al.
Journal of the Chinese Medical Association (2023) Vol. 86, Iss. 3, pp. 274-281
Open Access | Times Cited: 7
Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties – Evoking a synergistic strategy to combat COVID-19 pandemic
Nairah Noor, Adil Gani, Asir Gani, et al.
International Journal of Biological Macromolecules (2021) Vol. 180, pp. 375-384
Open Access | Times Cited: 17
Drug-Based Therapeutic Strategies for COVID-19-Infected Patients and Their Challenges
Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, et al.
Future Microbiology (2021) Vol. 16, Iss. 18, pp. 1415-1451
Open Access | Times Cited: 16
1H-Pyrazolo[3,4-b]quinolines: Synthesis and Properties over 100 Years of Research
Andrzej Danel, E. Gondek, Mateusz Kucharek, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2775-2775
Open Access | Times Cited: 10
Theta-Defensins to Counter COVID-19 as Furin Inhibitors: In Silico Efficiency Prediction and Novel Compound Design
Manica Negahdaripour, Mohammad Reza Rahbar, Zahra Mosalanejad, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 9
Correlation of Myeloid-Derived Suppressor Cell Expansion with Upregulated Transposable Elements in Severe COVID-19 Unveiled in Single-Cell RNA Sequencing Reanalysis
Mitra Farahmandnejad, Pouria Mosaddeghi, Mohammadreza Dorvash, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 315-315
Open Access | Times Cited: 1
Lessons from SARS‑CoV‑2 and its variants (Review)
Ziwen Qin, Yan Sun, Jian Zhang, et al.
Molecular Medicine Reports (2022) Vol. 26, Iss. 2
Open Access | Times Cited: 8
Forms and Methods for Interferon’s Encapsulation
Thelvia I. Ramos, Carlos A. Villacis-Aguirre, Nelson Santiago Vispo, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1533-1533
Open Access | Times Cited: 11
Tilorone and Cridanimod Protect Mice and Show Antiviral Activity in Rats despite Absence of the Interferon-Inducing Effect in Rats
Viktoriya Keyer, Laura Syzdykova, Gulzat Zauatbayeva, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 617-617
Open Access | Times Cited: 7
Post-COVID-19 Hyperglycemia: A Concern in Selection of Therapeutic Regimens.
Manica Negahdaripour
DOAJ (DOAJ: Directory of Open Access Journals) (2021) Vol. 46, Iss. 4, pp. 235-236
Closed Access | Times Cited: 8
Identification of Transcription Factors Regulating SARS-CoV-2 Tropism Factor Expression by Inferring Cell-Type-Specific Transcriptional Regulatory Networks in Human Lungs
Haonan Tong, Hao Chen, Cranos Williams
Viruses (2022) Vol. 14, Iss. 4, pp. 837-837
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top